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Programmed cell death has seemed to be regulated in
quite different ways in mammals and Drosophila.
Recent results on the way Ras and downstream
pathways can influence cell-death induction suggest
the regulatory pathways in these distinct organisms
might be more similar than was at first sight apparent.
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Programmed cell death, or apoptosis, is a critical factor in
homeostasis in all multicellular organisms, playing a
crucial role in removing excess unwanted cells without
stimulation of an immune response. In order to minimise
the risk of cells proliferating in an uncontrolled manner,
apoptosis is thought to act as a ‘default programme’ for
metazoan cells, which has to be suppressed at all times by
the action of survival signals. Some progress has been
made in understanding at the molecular level how survival
signals impact on the control of apoptosis in mammalian
cells in the past couple of years; now, two groups [1,2]
have used genetic approaches in Drosophila to determine
how the fly homologue of the Ras oncogene suppresses
apoptosis during the formation of the compound eye.
Most of our current understanding of apoptosis has
emerged from parallel molecular and cell biological
studies in mammalian systems and developmental
genetic analyses in the nematode worm Caenorhabditis
elegans. In the worm, 131 of a total of 1090 cells in the
organism die by suicide in a predictable manner. Three
genes play a critical role in the regulation of this cell
death, the pro-apoptotic ced-3 and ced-4 genes, and anti-
apoptotic ced-9 gene [3]. These three players correspond
to three families of key death regulators in the mam-
malian system: ced-3 encodes a caspase, the cysteine-
aspartate directed proteases that are responsible for
dismembering key cellular proteins, as well as being early
components of the signalling pathway for induction of
apoptosis. The product of ced-4 is an adaptor protein, the
mammalian homologue of which is Apaf1, which controls
activation of caspases, particularly by cytochrome c
released from mitochondria. And ced-9 encodes a homo-
logue of Bcl-2, the protective factor which is overex-
pressed in some tumours and which prevents activation of
executioner caspases via Apaf1.
Most of the apoptosis-regulating factors found in mammals
are also in place in worms, although the mammalian
system has enormously greater complexity, with large fam-
ilies of caspases and Bcl-2-related proteins. The only major
players in cell-death regulation in mammals that have not
been found in worms are the death receptors, such as
Fas/CD95 and tumour necrosis factor receptor I, and their
associated adaptors, such as FADD and TRADD. 
In the mammalian system, there has been much interest
recently in how growth factors and activated oncogenes
are able to suppress apoptosis. For example, many factors
that protect cells from apoptosis are able to stimulate the
activity of the lipid kinase, phosphoinositide 3-OH kinase
(PI 3-kinase). The lipids produced by this enzyme stimu-
late the activity of the protein kinase Akt, also known as
protein kinase B (PKB) [4]. This kinase is able to
phosphorylate and neutralise Bad, a pro-apoptotic
member of the Bcl-2 family that blocks Bcl-2 function by
heterodimer formation; Akt phosphorylation of Bad
prevents its binding to Bcl-2. Akt has also been reported
to phosphorylate and inactivate caspase-9 [5]. Another
commonly used anti-apoptotic signalling system in
mammals involves NF-κB, which again is activated in
response to a wide range of protective factors. Unlike the
Akt pathway, which appears to be largely independent of
transcriptional regulation, NF-κB acts by altering tran-
scription of responsive genes, in particular inducing the
expression of certain anti-apoptotic proteins such as the
‘inhibitor of apoptosis proteins’ (IAPs) [6].
The ability of some activated oncogenes to protect
tumour cells from apoptosis is likely to be very important
in promoting the disordered growth of these cells in the
absence of survival factors that is characteristic of cancer.
The mutationally activated ras oncogene, commonly
found in human tumours, has been shown to be able to
protect cells from apoptosis in some contexts, but also to
induce apoptosis in others. The response is partly depen-
dent on the cell type being studied, but also reflects Ras’s
ability to activate multiple signalling pathways directly at
the same time. Through its interaction with the protein
kinase Raf, Ras can activate the mitogen-activated
protein (MAP) kinase pathway, and through interaction
with the catalytic subunit of PI 3-kinase it can activate
Akt [7]. The Akt pathway has only ever been shown to
have anti-apoptotic consequences, but the MAP kinase
pathway can be pro-apoptotic under some conditions.
The complexity, context-dependence and lack of clarity
in this signalling network can be disheartening; it is
likely, however, that at least some of this complexity is
artifactual and reflects the non-physiological nature of the
experimental systems used, which may involve high
levels of overexpression of components, or the use of cell
lines that have undergone numerous other, usually
unknown, genetic changes.
The impact of Ras on cell death regulation has been crying
out for new experimental approaches. Now Kurada and
White [1] and Bergmann et al. [2] have turned the power of
Drosophila genetics towards analysing the influence of Ras
in the control of apoptosis in the fly eye. The picture that
emerges holds several surprises and implies that a number
of pieces may still be missing from our picture of the mam-
malian death-regulatory system. Studies of apoptosis in
Drosophila have revealed a number of familiar components,
such as caspases and IAPs, but many of the players essen-
tial in vertebrate and worm apoptosis, such as Bcl-2 pro-
teins or death receptors, have not been found in
Drosophila. Instead, three novel genes, reaper, grim and hid,
have been shown to be essential for most normal apoptosis
in Drosophila — without them, normal apoptosis in embry-
onic development does not occur and the embryos die [8].
Homologues of these genes have not been found in the
vertebrate or worm systems. So is cell death in Drosophila
entirely different from that in other systems? 
One clue to the roles these genes play may be found in
their expression patterns. Thus, grim and reaper expression
is restricted to those cells that will die, whereas hid is
expressed both in doomed cells and in cells that will
survive. Ectopic expression of any of these genes results
in excess cell death. The recent papers by Kurada and
White [1] and Bergmann et al. [2] use this observation to
identify other genes that may function together with these
‘death’ genes. Both groups used ectopic death-gene
expression in the fly eye to induce apoptosis, and
screened for dominant suppressors or enhancers of this
cell death. They both found that activation of the
Ras/MAP kinase pathway inhibits cell death controlled by
this complex of genes.
Kurada and White [1] screened for modulators of reaper-
induced death and found increased death resulting from
loss of Ras function, suggesting that Ras normally inhibits
reaper-induced death. Bergmann et al. [2] screened for mod-
















































Effects of Ras on apoptosis-regulating signalling pathways in (a) a
mammalian cell and (b) a fly cell. The major pathways discussed in the
text are shown; components in green act to inhibit apoptosis, whereas
those in red act to promote apoptosis. In mammals, Akt plays a major
role in the Ras suppression of apoptosis by phosphorylating Bad and
caspase-9; protective pathways downstream of Raf and MAP kinase
are less well defined. Ras also promotes survival by activation of
NF-κB and subsequent expression of anti-apoptotic proteins. No
mammalian Reaper has yet been identified, but it might exist and act
through Scythe to promote cytochrome c release from mitochondria. In
the fly eye cell, the major survival pathway downstream of Ras is
through suppression of hid transcription, and also inhibition of Hid
function by direct phosphorylation. The Akt pathway appears to plays a
lesser, though significant, role. Cytochrome c is likely to be involved in
apoptosis in the fly, although its function has not yet been
demonstrated genetically. Reaper, Grim and Hid act upstream of
caspases, although the details of the mechanism are unknown. Death
receptors have been identified in mammalian cells, but not yet in fly
cells, and act to induce caspase activation both directly and via
mitochondrial events. MAPK, MAP kinase; MAPKK, MAP kinase kinase.
(See text for details.)
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of a number of negative regulators of Ras activity. Both
groups found that activated Ras strongly inhibits the death
caused by ectopic expression of hid, although only Kurada
and White [1] saw an effect of Ras on reaper-induced death.
In contrast, the cell death induced by ectopic expression of
grim was found not to be affected by Ras, suggesting grim-
mediated cell death lies in a separate pathway.
One of the major pathways downstream of Ras is the MAP
kinase cascade, so both groups looked for effects of com-
ponents of this cascade on the induced cell death. They
found that loss of MAP kinase components enhanced cell
death, whereas their overexpression or activation inhibited
cell death. Activators of the Ras/MAP kinase pathway,
such as epidermal growth factor (EGF), were also found to
inhibit cell death. But how does the Ras/MAP kinase
pathway inhibit the cell death otherwise induced by Hid
and Reaper? Hid is clearly inhibited by activated
Ras/MAP kinase, but slightly different mechanisms are
proposed for how this occurs. 
Kurada and White [1] focussed their attention on the
control of hid expression, and found that activation of the
Ras/MAP kinase pathway led to a decrease in hid mRNA
level. Looking downstream of MAP kinase, they found
that two transcriptional targets of Ras in the eye, pnt and
yan, encode proteins that can also affect hid expression.
Pnt, a positive effector of the Ras pathway, was found to
downregulate hid transcript levels, whereas a negative
effector, Yan, was found to upregulate hid expression and
thereby induce cell death in the embryo. So it looks as
though Ras is acting through the same pathway — involv-
ing MAP kinase, Pnt and Yan — both to induce differen-
tiation and to inhibit cell death.
Bergmann et al. [2] concentrated on the control of Hid
activity. Hid protein contains MAP kinase consensus sites,
making it a likely target for phosphorylation. To test if
these putative MAP kinase sites are important, they sub-
stituted these residues by non-phosphorylatable amino
acids. This was expected to yield mutant forms of Hid
resistant to inactivation by MAP kinase and indeed, in
tissue culture assays and in vivo, the Hid mutants turned
out to be ‘superkillers’ which are resistant to Ras inactiva-
tion. It thus appears likely that Hid is regulated by the
Ras/MAP kinase pathway, both at the level of protein
phosphorylation and at the level of gene expression. 
How different are the cell death pathways in mammals and
flies? At first sight, it appears that apoptosis is controlled
quite differently in flies than in mammals. Hid, Grim and
Reaper have not been found in worms or mammals, and
upstream components such as Ced-9/Bcl-2 and death
receptors have not been found in flies. As these new
papers [1,2] indicate, however, there is a similarity in the
way Ras acts to prevent apoptosis in these phylogenetically
distinct organisms (Figure 1). In flies, the major survival
signalling pathway downstream of Ras in the eye is the
Raf/MAP kinase branch, which is not always protective in
mammals [7]. But the evidence reported by Bergmann et
al. [2] suggests that the PI 3-kinase/Akt branch of the Ras
pathway also contributes to the anti-apoptotic effects of
Ras in flies, as in vertebrates, although in flies the effects
are weaker than those of the Raf/MAP kinase branch. 
There are other similarities between the cell-death
machinery in flies and mammals. Thus, Drosophila
caspases, such as drICE [9] and Dcp-1 [10], have been
identified and shown to function in cell death. Another
similarity is that the loss of Drosophila Akt1 results in
ectopic cell death [11]. In addition, some components that
have only been found in one system or the other can
function in the heterologous system. The C. elegans genes
ced-3 and ced-9, when expressed in transfected Drosophila
cells, act in a similar manner as they do in C. elegans [12].
Mammalian Fas can also induce cell death in Drosophila
cells [13]. Conversely, Reaper and Grim can induce cell
death in mammalian cells [14] and can bind human IAPs,
which inhibit their ability to induce cell death. 
Might mammalian homologues of Grim, Hid and Reaper
exist after all? An apparent vertebrate target of Reaper has
recently been identified. This is Scythe, a protein found in
Xenopus egg extracts that interacts directly with Reaper and
apparently mediates its induction of cytochrome c release
from mitochondria and consequent caspase activation in
vitro [15]. This suggests that true vertebrate homologues of
Reaper are likely to exist. Furthermore, there might be
other cell death pathways in the fly that have not yet been
characterised: apoptosis is an essential part of Drosophila
oogenesis, yet this particular cell death has been shown to
proceed normally in flies lacking Grim, Hid and Reaper
[16]. So perhaps homologues of other mammalian death
regulators are important in regulating the apoptotic cell
death in Drosophila oogenesis. While it is still possible that
fly cells die in very different ways than those of mammals or
worms, things might turn out not to be so different after all.
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If you found this dispatch interesting, you might also want
to read the February 1999 issue of
Current Opinion in
Genetics & Development
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by Allan Balmain and Nicholas Dyson, on
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Ras caught in another affair: the exchange factors 
for Ral
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The full text of Current Opinion in Genetics &
Development is in the BioMedNet library at
http://BioMedNet.com/cbiology/gen
